DNA X, Inc. - 10-Q Filing
DNA X, Inc. filed its quarterly report for the period ended March 31, 2026, providing unaudited financial statements and updates on operations. The filing includes details about revenue, expenses (including research and development, selling and marketing, general and administrative), stockholders' deficit changes, cash flows, and notes to financial statements covering topics like convertible promissory notes, related party transactions, warrants, and subsequent events.
Tickers: $SONM